effect overlay
activetrials
Active Trials - Other
Traumatic Brain Injury (TBI)
Biomarkers for Brain Concussion

A prospective study of language function following surgical resection of left hemisphere primary brain tumours

HREC: 2015.012
Principal Investigator: A/Prof Sandy Shultz
Coordinator contact:
Funding: Non-Commercial
Active Trials - Other
Peripheral Neuropathy
Argenx BV

A Multicenter Prospective Longitudinal Study of Clinical Outcomes, Disease Course, Health-Related Quality of Life, and Health Care Resource Utilization in Adult Patients With Multifocal Motor Neuropathy (MMN)

HREC: 2024.051
Principal Investigator: Dr Belinda Cruse
Coordinator contact: Callum Hollis
Funding: Commercial
Active Trials - Other
Neuro-Ophthalmology
NODE Registry

Prospective Neuro-Ophthalmology database (NODE) towards developing comprehensive longitudinal outcome measures for neuro-ophthalmic diseases
 

HREC: 2020.336
Principal Investigator: Dr Anthony Fok
Coordinator contact:
Funding: Non-Commercial
Active Trials - Other
Huntington's Disease
Generation HD 2

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals with Prodromal and Early Manifest Huntington’s Disease
 

HREC: 2023.014
Principal Investigator: Prof Dennis Velakoulis
Coordinator contact: Anice Abin
Funding: Commercial
Active Trials - Other
NP Disease Type C (NP-C)
NPC Cyclo

A Phase 3, Double-blind, Randomized, Placebo-controlled, Parallelgroup, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of 2000 mg/kg of Trappsol® Cyclo™ (Hydroxypropyl-β-cyclodextrin) and Standard of Care Compared to Placebo and Standard of Care in Patients with Niemann-Pick Disease Type C1
 

HREC: 2021.078
Principal Investigator: Prof Piero Perucca
Coordinator contact: Lei Chen
Funding: Commercial